Increased serological, cancer-associated protein biomarker levels at diagnosis of large bowel adenoma: Risk of subsequent primary malignancy?

References

• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.
   PubMed Web of Science ®Google Scholar
• Brenner H, Kloor M, Pox CP. Colorectal Cancer. Lancet. 2014;383:1490–1502.
   PubMed Web of Science ®Google Scholar
• Nielsen HJ, Brünner N, Jørgensen LN, et al. Plasma TIMP-1 and CEA in detection of primary colorectal cancer: a prospective, population based study of 4509 high-risk individuals. Scand J Gastroenterol. 2011;46:60–69.
   PubMed Web of Science ®Google Scholar
• Singh R, Zorrón Cheng LTP, Koay D, Burt A. Sessile serrated adenoma/polyps: where are we at in 2016?. World J Gastroenterol. 2016;22:7754–7759.
   PubMed Web of Science ®Google Scholar
• Van der Stok EP, Spaander MCW, Grünhagen DJ, et al. Surveillance after curative treatment for colorectal cancer. Nat Rev Clin Oncol. 2017;14:297–315.
   PubMed Web of Science ®Google Scholar
• Bretthauer M, Kaminski MF, Løberg M, et al. Population-based colonoscopy screening for colorectal cancer: a randomized clinical trial. JAMA Intern Med. 2016;176:894–899.
   PubMed Web of Science ®Google Scholar
• Waldmann E, Heinze G, Ferlitsch A, et al. Risk factors cannot explain the higher prevalence rates of precancerous colorectal lesions in men. Br J Cancer. 2016;115:1421–1429.
   PubMed Web of Science ®Google Scholar
• Rex DK, Helbig CC. igh Yields of small and flat adenomas with high-definition colonoscopes using either white light or narrow band imaging. Gastroenterology. 2007;133:42–47.
   PubMed Web of Science ®Google Scholar
• IJspeert JEG, van Doorn SC, van der Brug YM, et al. The proximal serrated polyp detection rate is an easy-to-measure proxy for the detection rate of clinically relevant serrated polyps. Gastrointest Endosc. 2015;82:870–877.
   PubMed Web of Science ®Google Scholar
• Dube C, Yakubu M, McCurdy BR, et al. Risk of advanced adenoma, colorectal cancer, and colorectal cancer mortality in people with low-risk adenomas at baseline colonoscopy: A systematic review and meta-analysis. Am J Gastroenterol. 2017;112:1790–1801.
   PubMed Web of Science ®Google Scholar
• Levine JS, Ahnen DJ. Clinical practice. Adenomatous polyps of the colon. N Engl J Med. 2006;355:2551–2557.
   PubMed Web of Science ®Google Scholar
• Kelloff GJ, Schilsky RL, Alberts DS, et al. Colorectal adenomas: a prototype for the use of surrogate endpoints in the development of cancer prevention drugs. Clin Cancer Res. 2004;10:3908–3918.
   PubMed Web of Science ®Google Scholar
• Bretthauer M, Kalager M, Adami O. Do's and don'ts in evaluation of endoscopic screening for gastrointestinal cancers. Endoscopy. 2016;48:75–80.
   PubMed Web of Science ®Google Scholar
• Trimbath JDT, Giardiello FM. Review article: genetic testing and counselling for hereditary colorectal cancer. Aliment Pharmacol Ther. 2002;16:1843–1857.
   PubMed Web of Science ®Google Scholar
• Kennelly RP, Gryfe R, Winter DC. Familial colorectal cancer: patient assessment, surveillance and surgical management. Eur J Surg Oncol. 2017;43:294–302.
   PubMed Web of Science ®Google Scholar
• Lieberman DA, Harford WV, Ahnen DJ, et al. Veterans Affairs Cooperative Study Group 380. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med. 2001;345:555–560.
   PubMed Web of Science ®Google Scholar
• Niedermaier T, Weigl K, Hoffmeister M, et al. Flexible sigmoidoscopy in colorectal cancer screening: implications of different colonoscopy strategies. Eur J Epidemiol. 2018;33:473–484.
   PubMed Web of Science ®Google Scholar
• Nielsen HJ, Christensen IJ, Andersen B, et al. Serological biomarkers in triage of FIT-positive subjects?. Scand J Gastroenterol. 2017;52:742–744.
   PubMed Web of Science ®Google Scholar
• Løberg M, Kalager M, Holme Ø, et al. Long-term colorectal-cancer mortality after adenoma removal. N Engl J Med. 2014;371:799–807.
   PubMed Web of Science ®Google Scholar
• Kring TS, Piper TB, Jørgensen LN, et al. Blood-based biomarkers at large bowel endoscopy and prediction of future malignancies. Biomark Cancer. 2015;7:57–61.
   PubMedGoogle Scholar
• Hvolris MH, Piper TB, Hammer E, et al. Increased serological cancer-associated biomarker levels at large bowel endoscopy and risk of subsequent primary cancer. Scand J Gastroenterol. 2016;51:860–865.
   PubMed Web of Science ®Google Scholar
• Johansen JS, Christensen IJ, Jørgensen LN, et al. Serum YKL-40 in risk assessment for colorectal cancer: a prospective study of 4,496 subjects at risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2015;24:621–626.
   PubMed Web of Science ®Google Scholar
• Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496–509.
   Web of Science ®Google Scholar
• Rasmussen L, Wilhelmsen M, Christensen IJ, et al. Protocol outlines for part 1 and 2 of the prospective Endoscopy III study for the early detection of colorectal cancer: validation of a concept based on blood biomarkers. JMIR Res Protoc. 2016;5:e182.
   PubMedGoogle Scholar
• Allin KH, Bojesen SE, Johansen JS, et al. Cancer risk by combined levels of YKL-40 and C-reactive protein in the general population. Br J Cancer. 2012;106:199–205.
   PubMed Web of Science ®Google Scholar
• Kjaergaard AD, Nordestgaard BG, Johansen JS, et al. Observational and genetic plasma YKL-40 and cancer in 96,099 individuals from the general population. Int J Cancer. 2015;137:2696–2704.
   PubMed Web of Science ®Google Scholar
• Allin KH, Bojesen SE, Nordestgaard BG. Inflammatory biomarkers and risk of cancer in 84,000 individuals from the general population. Int J Cancer. 2016;139:1493–1500.
   PubMed Web of Science ®Google Scholar
• Holdenrieder S, Dharuman Y, Standop J, et al. Novel serum nucleosomic biomarkers for the detection of colorectal cancer. Anticancer Res. 2014;34:2357–2362.
   PubMed Web of Science ®Google Scholar
• Phallen J, Sausen M, Adleff V, et al. Direct detection of early stage cancers using circulating tumor DNA. Sci Transl Med. 2017;9:eaan2415.
   PubMed Web of Science ®Google Scholar
• Schøler LV, Reinert T, Ørntoft MW, et al. Clinical implications of monitoring circulating tumor DNA in patients with colorectal cancer. Clin Cancer Res. 2017;23:5437–5445.
   PubMed Web of Science ®Google Scholar
• Cohen JD, Li L, Wang Y, et al. Detection and localization of surgically resectable cancers with a multi-analyte blood test . Science. 2018;359:926–930.
   PubMed Web of Science ®Google Scholar
• Wilhelmsen M, Christensen IJ, Jørgensen LN, et al. Clean colorectum at diagnostic colonoscopy: subsequent detection of extra-colonic malignancies by plasma protein biomarkers? Biomark Cancer. 2018;10:1179299X1877697.
   Google Scholar